London, 30th September - The BMJ Group, one of the world’s most trusted providers of medical information for doctors, researchers, healthcare workers and patients, announces the launch of a new international advisory board to be chaired by Sir Charles George.

The Board will advise the Group on future trends in healthcare over the next 10–20 years so that the Group can continue to make a real difference in clinical practice and improve outcomes for patients.

Sir Charles George is currently Chairman of the British Medical Association’s Board of Science and Education and Emeritus Professor of Clinical Pharmacology at Southampton University.

Other members of the Board are:

Professor Howard Bauchner, Boston University Medical School, USA
Professor Peter Brooks, Executive Dean at the University of Queensland, Australia
Professor Sally Davies, Director General of Research and Development at the Department of Health, UK
Dr Simon Eccles, National Clinical Director of NHS Connecting for Health, UK
Dr Alejandro Jadad, Founder of the Centre for Global eHealth Innovation, Canada
Professor Parveen Kumar, past President of the BMA and Chairman of BMJ Learning Advisory Group, UK
Professor Martin Marshall, Clinical Director of the Health Foundation, UK
Dr Sharon Straus, Associate Professor at the University of Calgary and the University of Toronto, Canada

Stella Dutton, CEO of the BMJ Group said:
 
“I am delighted that we have brought together such a talented group of people to help advise us. One of the Advisory Board’s key tasks will be to help the Group build a picture of what healthcare will be like by 2020 and help us shape the Group’s future strategy, products and services to meet the needs of doctors and patients both in the UK and internationally.”